TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Form Specific Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Form Specific Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Form Specific Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Industry Landscape Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Form Specific Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Form Specific Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Form Specific Drugs industry

Ready To Use, Noradrenaline Drip Bags, Having Low Subvisible Particle CountsSINTETICAJun 17, 2025ZINNER
Capsule FormulationsCHEMOCENTRYXJun 12, 2025LEK PHARMACEUTICALS DD
Process Of Spray Drying Of Glp-1 PeptideNOVO NORDISKJun 11, 2025GENERICS UK
Modified Release Orally Administered Amino Acid FormulationsAPR APPLIED PHARMA RESEARCHJun 10, 2025MAIWALD
High Caloric, High Protein Nutritional FormulaFRESENIUS KABI DEUTSCHLANDJun 5, 2025SOCIETE DES PRODUITS NESTLE
Compositions Of 1-(4-Bromo-5-(1-Ethyl-7-(Methylamino)-2-Oxo-1,2-Dihydro-1,6-Naphthyridin-3-Yl)-2-Fluorophenyl)-3-PhenylureaDECIPHERA PHARMACEUTICALSMay 28, 2025ALFRED E TIEFENBACHER
Stable Secukinumab Injection And Preparation Method ThereforTONGHUA DONGBAO PHARMACEUTICALMay 14, 2025STRAWMAN
Cannabinoid PouchNORDICCANMay 7, 2025NICOVENTURES
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025MAIWALD
Treatment Of Sepsis And Septic ShockCOMBIOXINMay 6, 2025BRAND MURRAY FULLER

To stay ahead in the competitive Form Specific Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Form Specific Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
Nov 13, 2019Apixaban FormulationsPFIZER12
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
Dec 11, 2019Rapid Dissolution Formulation Of A Cinacalcet HclAMGEN11
Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS11
Oct 16, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND10
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
Nov 27, 2019Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGEN10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX10